|
Emerging Infectious Diseases
Introduction
Research Plans and Priorities
Fact Sheets and Brochures
News Releases
Reports and Articles from NIAID
Staff Presentations and Papers
Opportunities and Resources
Ongoing Research
Clinical Trials
Intramural Labs at NIAID
Meetings
Related Sites
See Also:
Division of Acquired Immunodeficiency Syndrome (DAIDS), and DMID Research Pages for Influenza, Lyme Disease, Hepatitis, Malaria, Tuberculosis, Global Health, Antimicrobial Resistance
Introduction
The problem posed by emerging and re-emerging infections is one of unparalleled complexity. Many infectious diseases can be expected to increase in incidence or change in distribution under conditions in which currently available control measures prove insufficient; the periodic epidemics of influenza or cholera experienced in the last century provide familiar examples. Research to improve the control of re-emerging pathogens follows established mechanisms, aimed primarily at discovery and development of new or improved vaccines and therapies. The emergence of new or altered pathogens will be unpredictable, however—occurring as a result of microbial evolution, changes in host-pathogen interaction, and a myriad of other factors.
NIAID Research Plans and Priorities
- Support the application of relevant scientific knowledge and new technologies to the detection, identification, and interdiction of emerging diseases, by expanding research on ecological and environmental factors influencing disease emergence and transmission.
- Support the application of recent discoveries and new biomedical technologies to the identification, management, and control of emerging diseases, by expanding research on microbial changes and adaptations that influence disease emergence.
- Provide fundamental information for developing prevention and treatment strategies that can be employed to ameliorate disease impact, by expanding research on host susceptibility to emerging or re-emerging pathogens.
- Support the development and validation of vaccines, therapeutics, and other control strategies for specific diseases with the potential to emerge or re-emerge.
- Strengthen the current U.S research and training infrastructure for detecting and responding to outbreaks of
infectious diseases.
Fact Sheets and Brochures
Top of Page
News Releases
DMID Press Releases
NIAID Newsroom
Reports and Articles from NIAID
Staff Presentations and Papers
- Emerging Microbes – John R. La Montagne, Ph.D., Director, Division of Microbiology and Infectious Diseases
- Emerging Diseases Research Agenda: Remarks of the Director, – Anthony S. Fauci, M.D., Director of NIAID [scroll down to heading]
- Infectious Diseases: Considerations for the 21st Century: The Challenges of Infectious Diseases Research – Anthony S. Fauci, M.D., Director of NIAID
- NIAID Targets Four Major Areas: Global Health and Emerging Infectious Diseases – Anthony S. Fauci, M.D., Director of NIAID
- The Role of US Government Agencies in Vaccine Research and Development, Successes and Challenges – Anthony S. Fauci, M.D., Director of NIAID [scroll down to paragraph on emerging diseases]
Opportunities and Resources
- Funding Opportunities and Information
- Researcher Resources
Top of Page
Ongoing Research
Top of Page
Clinical Trials
Federally and Privately Supported Clinical Trials: clinicaltrials.gov
Intramural Labs at NIAID
The following are only a few of the Intramural Laboratories within NIAID whose research may potentially enhance our understanding of emerging and re-emerging diseases.
- Laboratory of Clinical Infectious Diseases – conducts basic and clinical studies of important human infectious and immunologic diseases, with a particular focus on viral, fungal, and bacterial infections, and acquired and congenital immune disorders that may enhance their virulence and chronicity.
- Laboratory of Host Defenses – focuses on mechanisms of innate host defense and novel therapies directed against bacterial, fungal and viral pathogens.
- Laboratory of Infectious Diseases – focuses primarily on viruses that play an important role in disease of the respiratory and gastrointestinal tracts, the liver, and the reticuloendothelial system.
- Laboratory of Viral Diseases – carries out investigations on the molecular biology of viruses, the interactions of viruses with host cells, the pathogenesis of viral diseases, and host defense mechanisms.
- Laboratory of Human Bacterial Pathogenesis – studies the molecular basis of human bacterial pathogenesis
- Laboratory of Persistent Viral Diseases – is concerned with studies of persistent active or latent virus infections.
Meetings
See NIAID's Calendar of Events
Related Sites
Top of Page
|
